# Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma

> **NCT02584257** · PHASE3 · COMPLETED · sponsor: **Lupin, Inc.** · enrollment: 217 (actual)

## Conditions studied

- Mild Persistent Asthma

## Interventions

- **OTHER:** methacholine chloride
- **DRUG:** placebo ProAir HFA
- **DRUG:** ProAir HFA
- **DRUG:** Lupin albuterol HFA MDI
- **DRUG:** placebo Lupin albuterol HFA MDI

## Key facts

- **NCT ID:** NCT02584257
- **Lead sponsor:** Lupin, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2016-08
- **Final completion:** 2016-09
- **Target enrollment:** 217 (ACTUAL)
- **Last updated:** 2020-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02584257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02584257, "Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02584257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*